New Tags reflect changes to National Cancer Drugs List
Posted in News
As of January 12th, the National Cancer Drugs List is at version 1.19. In December, NICE approved or partially approved baseline funding for six new chemotherapy/disease combinations which will move from the Cancer Drugs Fund to baseline funding by March 2017.
New Define Tags are created for each version of the Fund where drugs are added or removed to baseline funding but only the two most recent versions are viewable. A NICE Tag is created for each new Technology Appraisal that NICE approves so items that have moved from the National Cancer Drugs Fund to NICE approval can be monitored by this route.